Calcium Glutonate Recall Issued Due to Microbial Contamination

Federal drug regulators are asking doctors to follow up with any patients who received calcium gluconate injections from Rx Formulations, because shots received from the compounding pharmacy may have been contaminated.  

On February 6, the FDA announced that testing has confirmed microbial contamination of at least one lot of Rx Formulations calcium gluconate 10% injections. The agency says that doctors should follow up with patients who received injections from the Arizona-based compounding pharmacy as a precaution.

In December, all of Rx Formulation’s sterile products were recalled after floating matter was observed in an unused, intact vial of calcium gluconate 10% from lot #778961 produced by Rx Formulations in Mesa, Arizona. Testing has now confirmed that it was microbial contamination.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Several other products were also recalled that were made in the same area of the facility and were supposed to be sterile, including magnesium sulfate, potassium phosphates 4.4 mEq/ml, oxytocin 10 Units/ml, sodium bicarbonate 8.4%, and bupivacaine 3%.

The FDA warns that contaminated shots could lead to adverse health consequences and possibly a serious infection. However, there have been no adverse events associated with the recalled compounded drugs to date.

The recall comes in the wake of a nationwide fungal meningitis outbreak that was tracked back to epidural steroid injections distributed by the now-defunct compounding pharmacy, New England Compounding Center (NECC). The outbreak lasted nearly a year, sickened more than 700 people and killed more than 60.

Like the recalled calcium gluconate injections, FDA investigators found visible contaminants floating in supposedly sterile injections.

The outbreak led to new compounding pharmacy rules, and fungal meningitis lawsuits pushed NECC into bankruptcy.

NECC has agreed to the creation of a $100 million settlement fund for victims and their families, and lawsuits are still pending against pain clinics and hospitals which distributed the contaminated shots.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.